» Authors » Christina Greenaway

Christina Greenaway

Explore the profile of Christina Greenaway including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 72
Citations 1666
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Passos-Castilho A, Murphy D, Blouin K, Benedetti A, Panagiotoglou D, Bruneau J, et al.
J Viral Hepat . 2023 Apr; 30(8):656-666. PMID: 37070269
Immigrants living in low hepatitis C (HCV) prevalence countries bear a disproportionate HCV burden, but there are limited HCV population-based studies focussed on this population. We estimated rates and trends...
12.
Harrison L, Bergeron G, Cadieux G, Charest H, Fafard J, Levade I, et al.
Ann Intern Med . 2022 Dec; 176(1):67-76. PMID: 36508736
Background: Monkeypox, a viral zoonotic disease, is causing a global outbreak outside of endemic areas. Objective: To characterize the outbreak of monkeypox in Montréal, the first large outbreak in North...
13.
Angelo K, Smith T, Camprubi-Ferrer D, Balerdi-Sarasola L, Diaz Menendez M, Servera-Negre G, et al.
Lancet Infect Dis . 2022 Oct; 23(2):196-206. PMID: 36216018
Background: The early epidemiology of the 2022 monkeypox epidemic in non-endemic countries differs substantially from the epidemiology previously reported from endemic countries. We aimed to describe the epidemiological and clinical...
14.
Greenaway C, Hargreaves S
J Travel Med . 2022 Oct; 29(7). PMID: 36193748
No abstract available.
15.
Darwish I, Harrison L, Passos-Castilho A, Labbe A, Barkati S, Luong M, et al.
PLoS One . 2022 Aug; 17(8):e0272953. PMID: 36001588
Background: Health care workers (HCW), particularly immigrants and ethnic minorities are at increased risk for SARS-CoV-2 infection. Outcomes during a COVID-19 associated hospitalization are not well described among HCW. We...
16.
Greenaway C, Makarenko I, Tanveer F, Janjua N
Can Liver J . 2022 Aug; 1(2):34-50. PMID: 35990716
Hepatitis C virus (HCV) is the leading cause of death from infectious disease in Canada. Immigrants are an important group who are at increased risk for HCV; they account for...
17.
Greenaway C, Fabreau G, Pottie K
CMAJ . 2022 Jul; 194(26):E911-E915. PMID: 35817429
No abstract available.
18.
Passos-Castilho A, Labbe A, Barkati S, Luong M, Dagher O, Maynard N, et al.
J Travel Med . 2022 Apr; 29(6). PMID: 35417000
Background: Ethnoracial groups in high-income countries have a 2-fold higher risk of SARS-CoV-2 infection, associated hospitalizations, and mortality than Whites. Migrants are an ethnoracial subset that may have worse COVID-19...
19.
Pareek M, Greenaway C
Lancet Public Health . 2022 Mar; 7(4):e292-e293. PMID: 35338848
No abstract available.
20.
Margineanu I, Rustage K, Noori T, Zenner D, Greenaway C, Pareek M, et al.
Euro Surveill . 2022 Mar; 27(12). PMID: 35332865
BackgroundMigrants in low tuberculosis (TB) incidence countries in the European Union (EU)/European Economic Area (EEA) are an at-risk group for latent tuberculosis infection (LTBI) and are increasingly included in LTBI...